156 related articles for article (PubMed ID: 6163806)
1. Mode of action of coronary arterial relaxation by prostacyclin.
Holzmann S; Kukovetz WR; Schmidt K
J Cyclic Nucleotide Res; 1980; 6(6):451-60. PubMed ID: 6163806
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin increases cAMP in coronary arteries.
Kukovetz WR; Holzmann S; Wurm A; Pöch G
J Cyclic Nucleotide Res; 1979 Dec; 5(6):469-76. PubMed ID: 231612
[TBL] [Abstract][Full Text] [Related]
3. [Adenosine-3',5'-monophosphate content and muscle tension in isolated coronary arteries under the effect of lanthanum ions].
Fermum R; Möritz KU; Schäfer U; Leibelt M
Biomed Biochim Acta; 1984; 43(11):1285-94. PubMed ID: 6085268
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
Yamamoto T; Satoh K; Nishimura T; Horikawa N; Mine T; Hirohashi T; Hara Y
Arzneimittelforschung; 1994 Apr; 44(4):483-90. PubMed ID: 8011001
[TBL] [Abstract][Full Text] [Related]
5. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I
Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184
[TBL] [Abstract][Full Text] [Related]
6. Effects of PGI2 and PGI analogues on cAMP levels in cultured endothelial and smooth muscle cells derived from bovine arteries.
Dembinska-Kiec A; Rücker W; Schönhöfer PS
Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):67-70. PubMed ID: 6154247
[TBL] [Abstract][Full Text] [Related]
7. Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.
Schrör K; Rösen P
Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan; 306(1):101-3. PubMed ID: 218118
[TBL] [Abstract][Full Text] [Related]
8. Relaxation of bovine coronary arterial smooth muscle by cyclic GMP, cyclic AMP and analogs.
Napoli SA; Gruetter CA; Ignarro LJ; Kadowitz PJ
J Pharmacol Exp Ther; 1980 Mar; 212(3):469-73. PubMed ID: 6153716
[No Abstract] [Full Text] [Related]
9. Endothelium-induced relaxation by acetylcholine associated with larger rises in cyclic GMP in coronary arterial strips.
Holzmann S
J Cyclic Nucleotide Res; 1982; 8(6):409-19. PubMed ID: 6309931
[TBL] [Abstract][Full Text] [Related]
10. Relaxation by prostacyclin (PGI2) and 7-oxo-PGI2 of isolated cerebral, coronary and mesenteric arteries.
Malomvölgyi B; Hadházy P; Magyar K; Kánai K; Simonidesz V
Acta Physiol Acad Sci Hung; 1982; 60(4):251-6. PubMed ID: 6764858
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2, and 4.
El-Haroun H; Bradbury D; Clayton A; Knox AJ
Circ Res; 2004 Feb; 94(3):353-61. PubMed ID: 14670842
[TBL] [Abstract][Full Text] [Related]
12. Prostacyclin (PGI2) mediates hypoxic relaxation of bovine coronary arterial strips.
Roberts AM; Messina EJ; Kaley G
Prostaglandins; 1981 Apr; 21(4):555-69. PubMed ID: 7019974
[TBL] [Abstract][Full Text] [Related]
13. Elevation of cyclic AMP by prostacyclin is accompanied by relaxation of bovine coronary arteries and contraction of rabbit aortic rings.
Vegesna RV; Diamond J
Eur J Pharmacol; 1986 Aug; 128(1-2):25-31. PubMed ID: 3019739
[TBL] [Abstract][Full Text] [Related]
14. [Dissociation of the action of isoprenaline on muscle tension and adenosine-3',5'-monophosphate synthesis in isolated coronary arteries under the effect of diisopropylfluorophosphate].
Fermum R; Möritz KU; Tofelde U
Biomed Biochim Acta; 1984; 43(11):1269-83. PubMed ID: 6099728
[TBL] [Abstract][Full Text] [Related]
15. Effects of prostaglandins E2, I2 and F2 alpha on the tone of isolated coronary arteries from alloxan-diabetic dogs.
Palik I; Koltai MZ; Hadházy P; Malomvölgyi B; Wagner M; Pogátsa G
Prostaglandins Leukot Med; 1982 Jun; 8(6):607-14. PubMed ID: 7051047
[TBL] [Abstract][Full Text] [Related]
16. Concentration and time-dependent relationships between isosorbide dinitrate-induced relaxation and formation of cyclic GMP in coronary arterial smooth muscle.
Galvas PE; DiSalvo J
J Pharmacol Exp Ther; 1983 Feb; 224(2):373-8. PubMed ID: 6130144
[TBL] [Abstract][Full Text] [Related]
17. The effect of the protein phosphatases inhibitor cantharidin on beta-adrenoceptor-mediated vasorelaxation.
Knapp J; Bokník P; Linck B; Lüss H; Müller FU; Nacke P; Neumann J; Vahlensieck U; Schmitz W
Br J Pharmacol; 1997 Feb; 120(3):421-8. PubMed ID: 9031745
[TBL] [Abstract][Full Text] [Related]
18. [Action mechanism of vascular spasmolytics. 5. Drug-related relaxation and adenosine-3',5'-monophosphate content of isolated coronary arteries under conditions of fluoride-induced contracture].
Fermum R; Möritz KU
Acta Biol Med Ger; 1979; 38(8):1211-23. PubMed ID: 231362
[TBL] [Abstract][Full Text] [Related]
19. PGI2 enhanced cAMP content in bovine coronary arteries in the presence of isobutylmethylxanthine.
Dembinska-Kiec A; Rücker W; Schönhöfer PS
Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):107-10. PubMed ID: 91976
[TBL] [Abstract][Full Text] [Related]
20. Relaxation of vascular smooth muscle by isoproterenol, dibutyryl-cyclic AMP and theophylline.
Webb RC; Bohr DF
J Pharmacol Exp Ther; 1981 Apr; 217(1):26-35. PubMed ID: 6259328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
